Author： Fotherby M.D.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.58, Iss.4, 1999-10, pp. : 663-674
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antihypertensive therapy in stroke: how low should you go?
Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. :
Access to resources
Recommend
PRoFESS: what strategy is best for secondary stroke prevention?
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :
What's new with alteplase in stroke?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?
Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. :
Organised Management Teams for Stroke: What Are They and What Are Their Advantages?
By Spriggs D.
CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. :